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SUMMARY 
Dental implants that are integrated into the jaw bones are widely used to replace lost teeth in 
human beings. Tooth-loss is often related to loss of the surrounding alveolar bone. This can 
make implant placement difficult and a bone substituting material may be required. The 
standard method is to use a bone graft harvested from the patient which requires additional 
surgery than that needed for implant placement. Limitations in the amount of bone that can be 
harvested also pose a problem. In order to decrease the need for bone grafts, materials that can 
serve as substitutes and stimulate bone growth have been, and are being, developed.  
 
In this pilot study the research protocol for an in vivo experiment with a new calcium 
phosphate bone augmenting ceramic material, was evaluated. Two titanium screw type dental 
implants were placed in each tibial diaphysis of three, 12 month old, female New Zealand 
White rabbits. The implants where either surrounded by the experimental material, 
Straumann®BoneCeramic (positive control) or blood (negative control).  
 
For one week before as well as post-surgery the rabbits’ body weights were recorded daily. 
Each rabbit’s general condition, state of surgical wounds and the grade of limping was 
evaluated every day for as long as needed. Two weeks post-surgery an injection of a bone 
marker (calcein green) was planned. Three month post-surgery the rabbits were to be 
euthanized and the amount of newly formed bone evaluated with light microscopy. The 
osseointegration of the implants was to be measured histomorphometrically as the bone to 
implant contact in percent. However, the calcein green was never given and the bone 
formation and osseointegration never evaluated. All rabbits had to be euthanized within 24 
days post-surgery because of fractures appearing in one or both tibia/e.  
 
Apart from the pilot study, the master thesis includes a literature review of dental implants, 
bone augmenting materials and how the rabbit can be used as an animal model in dental 
implant research. 
 
SAMMANFATTNING 
Tandimplantat som integreras i käkbenet används flitigt inom humantandvården för att ersätta 
förlorade tänder. Förlust av tänder hänger ofta ihop med förlust av det omgivande 
alveolarbenet. I och med detta kan ett bensubstitut behövas för att implantatet ska kunna 
sättas in. Standardmetoden är att använda ett kroppseget bentransplantat. Detta medför att 
patienten behöver genomgå fler operationer än vad som krävs om implantatet kan sättas in 
direkt och det är också en begränsad mängd ben man får tillgång till på detta sätt. För att 
minska behovet av bentransplantat utvecklas material som kan ersätta ben och stimulera 
bentillväxt. 
 
I pilotstudien som beskrivs här utvärderades ett försöksprotokoll inför en studie av ett nytt 
benstimulerande keram baserat på kalciumfosfat. I piloten användes 3 stycken 12 månader 
gamla New Zealand White kaniner av honligt kön. Två skruvformade tandimplantat av titan 
sattes in i vardera tibiadiafys. Implantaten omgavs antingen av det experimentella materialet, 
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Straumann® BoneCeramic (positiv kontroll) eller blod (negativ kontroll). 
 
Under en vecka före såväl som efter efter operationerna vägdes kaninerna dagligen. Deras 
allmäntillstånd, operationssår och grad av hälta utvärderades varje dag så länge som det 
behövdes. Två veckor efter operationerna var planen att injicera en benmarkör, calcein grön, 
och tre månader efter operationen skulle kaninerna avlivas och bentillväxten utvärderas med 
ljusmikroskop. Osseointegrationen av implantaten skulle mätas histomorfometriskt som 
kontakten mellan implantat och ben i procent. Alla kaniner avlivades dock innan tre månader 
gått p.g.a. att de frakturerade en eller båda tibia/e inom 24 dagar efter operationen.  
 
Utöver pilotstudien innehåller examensarbetet också en litteraturstudie om tandimplantat, 
material som främjar bentillväxt och om hur kanin kan användas som modelldjur vid 
forskning kring tandimplantat.  
 
INTRODUCTION 
Dental implants are used to replace lost teeth and to correct various types of defects (as 
reviewed by Xie et al., 2012). The method where titanium implants are integrated into the jaw 
bones has been used since the 1960’s (Brånemark et al., 1977). However the traditional 
method of placement requires a long period of healing (as reviewed by Henry and Liddelow, 
2008) and at least two surgical procedures since a two-step surgical protocol is used (as 
reviewed by Gapski et al., 2003). If the patient also needs an autogenous bone graft to the 
implantation site he or she must undergo additional surgery before the implant can function as 
a regular tooth. Current research aims to shorten the treatment time and minimize the surgical 
trauma to the patient (as reviewed by Henry and Liddelow, 2008). This can be achieved with 
materials that stimulate bone formation around implants (as reviewed by Xie et al., 2012). 
 
This master thesis includes an in vivo experiment and a literature review.  
 
A team from the Department of Chemistry at Ångström, Uppsala University and the 
Stockholm Craniofacial Centre at the Karolinska University Hospital has developed a new 
injectable calcium phosphate ceramic compound, the “Ångström ceramic”, based mainly on 
monetite. The aim is to use the material for bone augmentation around dental implants in 
humans. The material has been tested in vitro and before it can be considered safe for human 
use it must also be evaluated in an animal model. Justifications for the use of experimental 
animals in the testing of biomedical devices are outlined in an International Standard 
regarding animal welfare requirements (International Standard, ISO 10993-2: 1996). The 
research team has an approval from the local ethical committee to use 12 rabbits in the 
experiment (Dnr C131/11). This master thesis describes a pilot study, using three of these 
rabbits, carried out to evaluate the experimental protocol. The pilot study was conducted in 
collaboration with the Deparment of Clinical Sciences at the Swedish University of 
Agricultural Sciences.  
 
The purpose of the literature review is to provide a background for the pilot study and to point 
out pros and cons with the chosen animal model.  
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In order to understand how the rabbit can be used as an animal model in dental implant 
research it is important to know some facts about dental implants and common problems 
associated with implant placement. This is covered in the background, which also contains a 
short summary of materials used for bone augmentation. Furthermore, it is important to 
comprehend the structure and formation of bone tissue in order to understand the different 
materials that can be used to replace it.   
 
BACKGROUND  
Dental implants 
In the year of 2000 there were almost 100 different dental implant designs on the market 
(Binon, 2000). Described here are the type of implants that are integrated into bone and 
different ways to augment the bone formation around them. Formation and maintenance of 
enough bone at the implantation site is important for the short and long term success of this 
type of dental implants  (as reviewed by Masuda et al., 1998). 
 
Endosseous alloplastic implants – short summary 
Endosseous implants are implants placed within bone (as reviewed by Davies, 2003), and 
alloplastic means that they are made of non-biological material. Titanium is a material widely 
used for dental and orthopedic implants since it can be incorporated into bone with good 
biocompatibility (as reviewed by Marco et al., 2005). Standard dental implants have a 
diameter of 3-5 mm and a length of 6-15 mm (as reviewed by Huang et al., 2005). 
 
An endosseous dental implant consists of three different parts: an implant body that is 
integrated into the bone, an abutment which is an anchor that connects the implanted body 
with the dental prosthesis, and the dental prosthesis itself (see figure 1). These can either be 
separate parts that are put together in certain steps when the implant is placed, or they can all 
be in one part from the beginning (as reviewed by Prasad et al., 2011). The implant bodies 
come in many different shapes (as reviewed by Binon, 2000), for example they can be 
fashioned like screws or flat cylinders. 
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Figure 1. Schematic illustration of dental implant (grey) and abutment (yellow) between two regular 
teeth. By Lovisa Nalin based on the information from Prasad et al., 2011. 
 
There are three different methods for how and when an endosseous implant can be placed; 
immediate, early and delayed loading (as reviewed by Gapski et al., 2003 and Prasad et al., 
2011). Delayed loading is the traditional method used since the sixties  (as reviewed by Henry 
and Liddelow, 2008). It means that the implant body is placed into the bone, left to be 
integrated and then loaded with the abutment and prosthesis several months later. After 
implantation, the gum is sutured over the area (as reviewed by Gapski et al., 2003). The 
implant is then said to be submerged (Prasad et al., 2011). With this method the tissue around 
the implant can heal without contact with the oral cavity and without being affected by the 
occlusal forces. This prevents movement of the implant and minimizes the risk for infection 
and ingrowth of epithelium (as reviewed by Gapski et al., 2003). The procedure requires two 
surgeries since the gum must be reopened to place the abutment (as reviewed by Gapski et al., 
2003).  
 
Immediate and early loading are newer techniques where the tooth prosthesis is put into place 
immediately or within weeks after the implantation (as reviewed by Gapski et al., 2003 and 
Henry and Liddelow, 2008) . The advantages of immediate loading is that it only requires one 
surgical procedure, it shortens the treatment time and is more convenient for the patient (as 
reviewed by Gapski et al., 2003). The problem with this method is to get the implant properly 
integrated into the bone, but with new materials and methods this has become possible under 
the right circumstances (as reviewed by Gapski et al., 2003).  
 
One very important factor that determines when an implant can be loaded is the amount of 
bone at the implantation site. Enough bone of the right quality is important to ensure an early 
stable fixation of the implant which shortens the time before the implant can be loaded (as 
reviewed by Marco et al., 2005) and therefore the treatment time. 
 
Structure, formation and repair of bone tissue 
Bone is a highly specialized connective tissue built up by intercellular calcified bone matrix, 
osteogenic cells, i.e. osteoblasts, osteocytes and osteoclasts, and vasculature.  
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Bone matrix 
The bone matrix consists of both inorganic and organic matter. Calcium and phosphor are the 
main components of the inorganic part (Junqueira and Carneiro, 2005). They form 
hydroxyapatite crystals and non-crystalline forms of calcium phosphate. The organic part is 
made of type 1 collagen and ground substance (proteoglycan aggregates and glycoproteins) 
(Junqueira and Carneiro, 2005). This composition makes bone both hard and flexible. If the 
minerals are removed, the shape of the bone is maintained but it becomes as flexible as 
tendon. If the organic part is removed instead, the bone becomes brittle and fragile (Junqueira 
and Carneiro, 2005).  
 
Bone types 
Macroscopically bone can be divided into compact (cortical) and cancellous (spongy, 
trabecular) bone. Microscopically the basic histological structure of the bone types is the same 
(Junqueira and Carneiro, 2005). The compact bone is dense whereas the cancellous bone 
consists of trabeculae and numerous interconnecting cavities (Junqueira and Carneiro, 2005). 
A long bone can be divided into different parts: two epiphyses, two metaphyses and a 
diaphysis (Ross and Pawlina, 2011). The epiphyses are the most proximal and distal parts of 
the bone, separated from the metaphyses by the epiphyseal lines which are rests of the 
epiphyseal growth plates. The metaphyses are the parts between the epiphyseal lines and the 
shaft of the bone which is called the diaphysis (Ross and Pawlina, 2011) see figure 2. The 
epiphysis of long bones (e.g. the femur and tibia) consists to the greatest part of cancellous 
bone (the medullae) covered only by a thin layer of compact bone (the cortex) at the surface 
(Junqueira and Carneiro, 2005). The diaphysis on the other hand, is built up mostly by 
compact bone with only a thin core of cancellous bone surrounding the bone marrow cavity. 
 
 
Figure 2. Schematic illustration of the different parts of a long bone. 1 = epiphysis, 2 = metaphysis, 3 
= diaphysis. The white lines represent the ephiphyseal lines. By Lovisa Nalin based on information 
from Ross and Pawlina, 2011. 
 
Microscopically bone can be divided into primary (immature, woven) and secondary (mature, 
lamellar) bone tissue (Junqueira and Carneiro, 2005). Primary bone is characterized by a 
woven structure where the collagen fibers are un-organized. It also has a lower mineral 
density (darker on X-rays) and more osteocytes than mature bone and is the first bone to form 
in embryos and in bone repair (Junqueira and Carneiro, 2005). With a few exceptions (e.g. 
bone symphyses) this bone type is eventually replaced with mature bone which is 
characterized by a well-organized structure where the collagen fibers are arranged in lamellae, 
  1      2                                                            3                                                            2      1 
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see figure 3 (Junqueira and Carneiro, 2005). A Haversian system (or osteon) is formed by 
multiple lamellae surrounding a canal with nerves, blood vessels and connective tissue 
(Junqueira and Carneiro, 2005). Cementing substance surrounds each haversian system 
(Junqueira and Carneiro, 2005) and can be seen as cement lines marking the border of the 
same (as reviewed by Davies, 2003). They form at the interface were old bone has been 
resorbed and new bone is being laid down (as reviewed by Marco et al., 2005). 
 
 
Figure 3. Schematic illustration of four Haversian systems. The middle one in the front is drawn 
elevated to illustrate how the lamellae surround the central canal (pink). By Lovisa Nalin based on 
information from Junqueira and Carneiro, 2005. 
 
Bone formation and fracture repair 
Bone can form in two different ways, intramemranous ossification and endochondral 
ossification.  In the first case osteoid produced by osteoblasts is mineralized directly and in 
the second a hyaline cartilage template is first produced and then mineralized. In both cases 
primary bone is the first to appear and is later remodeled into secondary bone. The mandible 
and maxillae are formed through intramemranous ossification whereas the long bones are 
formed through endochondral ossification (Junqueira and Carneiro, 2005). 
 
When bone is damaged cells at the site of injury dies and the matrix is destroyed. The 
bleeding from damaged vessels results in the formation of a blood clot (Junqueira and 
Carneiro, 2005). This initiates an inflammatory cascade. Important signaling factors during 
fracture healing are pro-inflammatory cytokines (interleukin-1 and 6, tumor necrosis factor-α) 
and growth factors (as reviewed by Hallman and Thor, 2008). The pro-inflammatory 
cytokines attract inflammatory cells, stimulate angiogenesis and accelerates matrix production 
(as reviewed by Hallman and Thor, 2008). Growth factors from the growth factor-β 
superfamily (bone morphogenic proteins, growth factor- β) stimulate new bone formation (the 
bone morphogenic proteins can even induce ectopic bone formation i.e. are osteoinductive) 
(as reviewed by Hallman and Thor, 2008). Other important growth factors during fracture 
healing are platelet derived growth factor, insulin like growth factor 1 and 2, fibroblast growth 
factor and growth factors involved in angiogenesis (as reviewed by Hallman and Thor, 2008). 
Mesenchymal stem cells in the area are activated and recruited by the released signaling 
factors and differentiate into bone forming cells (as reviewed by Albrektsson and Johansson, 
2001). The periosteum and endostium proliferates and grow across the fracture ends to form a 
callus and during reparation the blood clot and the damaged tissue is removed by 
 7 
macrophages (Junqueira and Carneiro, 2005). Primary bone is formed both through 
intramembranous and endochondral ossification (Junqueira and Carneiro, 2005). This bone is 
then gradually remodeled into secondary bone. 
 
Cancellous bone is connected to the bone marrow which contains a rich vasculature and 
mesenchymal stemcells, this bone therefore heals and remodels faster than cortical bone (as 
reviewed by Davies, 2003) 
 
Teeth and bone 
The alveolar bone (also called alveolar ridge or process) is the part of the mandibula and 
maxillae that surrounds the teeth. In other words it constitutes the tooth sockets. The alveolar 
bone ends at the level of the tooth cervix and this border is called the alveolar crest. Together 
with the periodontal ligament and cementum of the teeth it forms the periodontium, the 
anchorage between teeth and bone. The bone lining the insides of the tooth sockets is called 
the alveolar bone proper and is made of compact bone (Bath-Balogh and Fehrenbach, 2011). 
The exterior of the tooth sockets are made of compact and cancellous bone and this is called 
the supporting alveolar bone (Bath-Balogh and Fehrenbach, 2011). The compact part of the 
supporting alveolar bone constitutes the facial and lingual part of the tooth sockets. Between 
this compact bone and the alveolar bone proper the cancellous part of the supportive alveolar 
bone is found. The bone between the roots of the teeth is composed of the alveolar bone 
proper and cancellous bone. The bone most apical to the roots is called the basal bone and is 
part of the mandibular and maxillar bodies (Bath-Balogh and Fehrenbach, 2011). 
 
The alveolar bone requires functional stimulation from speech and mastication to be 
preserved, so if a tooth is lost the alveolar bone is resorbed all the way down to the basal bone 
(Bath-Balogh and Fehrenbach, 2011). This mechanism can be prevented by installing a dental 
implant (Bath-Balogh and Fehrenbach, 2011). Since the teeth are anchored to the alveolar 
bone the opposite mechanism is also a fact, if the bone is resorbed the teeth are lost. 
 
Bone healing around dental implants 
Brånemark et al. (1977) were the first to suggest that there could be a direct anchorage 
between bone and implant and introduced the term osseointegration. 
 
Osseointegration 
When an implant is inserted into the jawbone it can be integrated into the bone tissue with 
direct contact between implant and bone, or it can heal with a fibrous capsule around it (as 
reviewed by Esposito et al., 1998b, Gapski et al., 2003 and Marco et al., 2005). The latter 
happens when primary stability is not achieved and the implant moves during integration (as 
reviewed by Marco et al., 2005). An implant is properly osseointegrated if the clinically 
assymptomatic rigid fixation between the alloplastic material and bone can be maintained 
during the loading of the implant (as reviewed by Albrektsson and Johansson, 2001). If there 
is fibrous tissue around the implant, osseointegration is not possible and the anchorage is then 
not sufficient for a tooth prosthesis to function as a regular tooth (as reviewed by Gapski et 
al., 2003 and Marco et al., 2005). This can be put in contrast to the fact that natural teeth are 
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surrounded by soft tissue, the periodontal ligament. This ligament is however highly 
specialized and nothing like the unorganized soft tissue capsule, and so far no one has 
managed to reconstruct the periodontal ligament around an implant (Albrektsson, 1995). This 
means that a successfully integrated implant is rigidly fixated to the bone and therefore loaded 
immediately when a force is applied as opposed to the natural teeth which, since they are 
anchored to the bone by the periodontal ligament, are able to move slightly in the alveolar 
sockets and distribute the force (as reviewed by Rangert et al., 1997).  
 
The amount and type of bone at the implantation site affects the primary stability (as reviewed 
by Esposito et al., 1998b, Gapski et al., 2003 and Marco et al., 2005). Bone is divided into 4 
different categories in the dental implant field based on the proportions between compact and 
cancellous bone (as reviewed by Davies, 2003). Class 1 bone consists primarily of compact 
bone and class 4 mostly of cancellous bone. The bone in the anterior mandible is often class 1 
bone whereas the bone in the posterior maxilla frequently is class 4. Compact bone provides a 
better anchorage than cancellous and therefore gives a better primary stability (as reviewed by 
Davies, 2003). Because of this Class 4 bone is often referred to as “poor quality bone” 
meaning that the quality is poor when it comes to the placement of implants and not that the 
bone is biologically impaired (as reviewed by Davies, 2003). As previously mentioned, 
cancellous bone actually remodels and heals faster than compact bone. 
 
Mechanisms of bone healing around implants 
The tissue in the drilled cavity into which the implant is put acts like the fracture repair in a 
common bone wound (as reviewed by Marco et al., 2005) but without endochondral 
ossification (as reviewed by Esposito et al., 1998b). The local tissue trauma caused by the 
drilling in the bone gives rise to an inflammation cascade. The bone implant interface is 
covered with blood, a clot forms and inflammatory cells migrate to the area (as reviewed by 
Davies, 2003). Damaged bone is broken down by osteoclasts and new bone is formed on top 
of it by osteoblasts. This new formation can occur in two different ways, distance 
osteogenesis or contact osteogenesis (as reviewed by Davies, 2003). In distance osteogenesis 
new bone is laid down on the peri-implant bone surfaces and the bone growth is directed 
towards the implant until it is surrounded and integrated into the bone. In contact osteogenesis 
bone forming cells colonize the implant surface and new bone is formed directly on it. This 
mimics the events were new bone is laid down on the surface of old resorbed bone and a 
cement line is formed between the implant and the new bone. Both types of bone formation 
occur at all implantation sites but the implant surface can be modified to enhance contact 
osteogenesis which provides a better primary stability. This is described in more detail in the 
section “Materials used for bone augmentation”. 
 
Implant failure  
There are many reasons why a dental implant may be considered to have failed. There can be 
something wrong with the implant, abutment or dental prosthesis (mechanical failure), the 
patient may not be satisfied with the result (patient related failure) or it might not have been 
put in properly (iatrogenic failure) (Esposito et al., 1998a). Apart from these factors implants 
fail because they are inadequately osseointegrated (biological failure) (Esposito et al., 1998a). 
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This can either be early in the process if the bone-implant contact is inadequate (as reviewed 
by Marco et al., 2005) or if the healing process is disturbed (as reviewed by Esposito et al., 
1998a), or later when a so far successfully osseointegrated implant fails because 
osseointegration is lost . This can happen if the tissues around the implant become chronically 
inflamed (peri-implantitis) or if the bone quality and volume in the area are not sufficient to 
bear the occlusal load (as reviewed by Esposito et al., 1998b). The same authors discuss that 
if a dental implant is subjected to great loads, micro fractures can arise in the surrounding 
bone, resulting in stress fractures at the bone-implant interface if the breakdown is faster than 
the repairing processes. The load that an implant can withstand depends on the capacity of the 
bone, the implant and the prosthesis design, therefore the forces the implant will be subjected 
to need to be evaluated before the implant is placed so that appropriate implant designs and 
placement methods can be chosen (Ranger et al., 1997).  
 
To ensure satisfactory osseointegration it is important to have a sufficient bone volume at the 
implantation site from the beginning (as reviewed by Chiapasco et al., 2009). As previously 
mentioned the alveolar bone atrophies when a tooth is lost and vice versa, the teeth are lost if 
the bone atrophies (Bath-Balogh and Fehrenbach, 2011). The latter is often the result of 
periodontal disease where the bone is broken down due to chronic inflammation in the 
structures surrounding the teeth. Old age and smoking are risk factors for severe disease and 
systemic metabolic diseases that affect bone can also lead to alveolar resorption (as reviewed 
by Bodic et al., 2005). Atrophy of the alveolar ridge both in height and width can make 
implant placement difficult (Hobkirk and Watson, 1995)  
 
Bone augmenting procedures may therefore be needed before an implant can be placed or 
bone augmenting materials can be used when the implant is installed to speed up the bone 
formation.  
 
Materials used for bone augmentation 
Bone grafts or alloplastic bone substitutes are used to augment bone at implantation sites 
where there is not enough. They provide the structural base for new bone that can support the 
dental implant (as reviewed by Xie et al., 2012). One important characteristic is that the 
material can function as a “spacemaker” and maintain the area where new bone is meant to 
form, even if it is affected by compressing forces (as reviewed by Thomas and Puleo, 2009). 
An ideal material is degraded and completely replaced by bone, but a fast degradation time 
can cause problems in some clinical situations (as reviewed by Thomas and Puleo, 2009). For 
example the esthetic result may be compromised (as reviewed by Hallman and Thor, 2008). 
 
Bone cells can be attracted to grow both by osteoinduction and osteoconduction. 
Osteoinduction is the mechanism in which mesenchymal stem cells are activated to 
differentiate into bone forming cells (as reviewed by Albrektsson and Johansson, 2001) and if 
an agent is truly osteoinductive it can induce bone formation at extra skeletal sites, for 
example in muscle. Osteoinduction naturally takes place when undifferentiated cells are 
activated by the signaling factors released due to bone injuries (e.g. fracture, introduction of 
an implant) (as reviewed by Albrektsson and Johansson, 2001) and a material that is in itself 
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osteoinductive can shorten the healing process around an installed implant (as reviewed by 
Hallman and Thor, 2008). 
 
Osteoconduction is when bone is allowed to grow on a surface, for example on an implant or 
synthetic bone substitute (as reviewed by Albrektsson and Johansson, 2001). All materials are 
not osteoconductive, for example bone cannot grow on silver or copper, and if these materials 
are placed into bone they are permanently encapsulated by soft- tissue (Albrektsson, 1995). 
Osteoconduction is perhaps the most important quality of bone augmenting materials since 
osteoinduction, as previously described, always takes place at the site of a bone injury even if 
the material itself is not osteoinductive  (Albrektsson and Johansson, 2001). 
 
A substitute material must be biocompatible (not toxic to cells), not evoke an immunogenic 
response and not give rise to chronic inflammation (as reviewed by Rezwan et al., 2006) and 
when degraded it should be into products that the body can metabolize and/or excrete (as 
reviewed by Chaikof et al., 2002). Another requirement is that it must be easy to sterilize (as 
reviewed by Chaikof et al., 2002). 
 
The ideal substitute would be able to release osteoinductive substances in a safe way, 
stimulate cell adhesion and proliferation and support the dental implant (as reviewed by Xie et 
al., 2012). It should also be resorbed and eventually fully replaced by bone (as reviewed by 
Tamimi et al., 2010), ultimately within a well-defined time frame (as reviewed by Thomas 
and Puleo, 2009). This is what research today aims to find. 
 
Bone grafts 
The standard method of bone augmentation is to use an autogenous bone graft (as reviewed 
by Xie et al., 2012). This type of graft is both osteoinductive, since it contains viable cells and 
proteins that stimulate osteogenesis, and osteoconductive as it works as a scaffold for new 
bone formation (as reviewed by Hallman and Thor, 2008). Autogenous bone grafts are 
harvested from the patient from intra oral sites, the iliac crest or the calvarium (as reviewed by 
Junker et al., 2009). If much bone is needed it is taken from the iliac crest (as reviewed by 
Hallman and Thor, 2008). The implant is either placed right away or several months after the 
graft have been put in place (as reviewed by Junker et al., 2009). Consequently this means 
that the patient has to go through one or two more operations, than the one or two needed for 
implant placement if a bone graft is not needed. All in all four operations might be necessary: 
one for harvesting the graft, one for inserting it, one for placing the implant and one for the 
attachment of the abutment and prosthesis.  
Because of this patient inconvenience, limited availability of bone and also unpredictable 
graft resorption times, alternative methods have been invented (as reviewed by Hallman and 
Thor, 2008).  
 
Bone grafts can also be allografts (derived from another individual of the same species) or 
xenografts (derived from another species). The risk with using grafts from another source than 
the own body are immunologic rejections and spreading of diseases.  
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In bone allografts there are no viable cells, but since they contain bone stimulating proteins 
they are still osteoinductive (as reviewed by Hallman and Thor, 2008). However, to reduce 
the immunogenicity of allografts they have to be processed in different ways, for example by 
freeze-drying, and this makes them less osteoinductive and osteoconductive than augografts 
(as reviewed by Habibovic and de Groot, 2007). Freeze-dried and demineralized freeze-dried 
allografts are the most commonly used allografts in implant dentistry and they are usually 
mixed with autogenous bone (as reviewed by Hallman and Thor, 2008).  
 
Xenografts consist of bone minerals and are depleted of all proteins (to eradicate host 
immunologic reactions) (as reviewed by Hallman and Thor, 2008). Because of this they lack 
osteoinductive capacities and only function as osteoconductive scaffolds. Deproteinized 
bovine bone is the most researched material and since it resembles human bone it is often 
used in implant dentistry (as reviewed by Hallman and Thor, 2008).  
 
Alloplastic bone substitutes 
Calcium phosphates, calcium sulphate, bioactive glasses and glass ceramics are bioceramic 
materials used to replace and substitute bone (as reviewed by Eppley et al., 2005, Vallet-Regi, 
2006 and Hallman and Thor, 2008). These materials are bioactive, which means that they can 
induce or modulate biological activity, and through this form a bond with living bone (as 
reviewed by Frayssinet et al, 1999). Calcium phosphates are very similar to the inorganic part 
of bone and have attracted a lot of attention in the field. 
 
Ceramic materials come in different forms: dense blocks, porous solid pieces, granulates and 
injectable solutions (as reviewed by Vallet-Regi, 2006). Recent research shows that the bone 
substitutes should be porous with a certain size of the pores since this is important for their 
resemblance to real bone and bone healing properties (as reviewed by Hallman and Thor, 
2008). Pore size is important for the vascularisation and oxygenation needed for new bone 
formation throughout the ceramic material. Without the right porous structure bone is only 
formed on the outer surface (as reviewed by Vallet-Regi, 2006). Despite this, many 
commercially available alloplastic bone substitutes are non-porous (as reviewed by Hallman 
and Thor, 2008). A problem in making a ceramic material porous is that its mechanical 
properties then can be impaired (as reviewed by Rezwan et al., 2006). 
 
Bioceramics are osteoconductive. Calcium phosphates and glass ceramics can also, with the 
right chemical composition, micro- and macrostructure, be made osteoinductive although the 
complete mechanism for this is not understood (as reviewed by Habibovic and de Groot, 
2007). 
 
A recent trend in material chemistry is to also use the ceramic materials as delivery vehicles 
for drugs or growth factors (as reviewed by Vallet-Regi, 2006). The idea is that the delivered 
substances will be gradually released and then be able to act locally at the implant site, for 
example to prevent infections or stimulate bone growth.  
 
Another category of materials that can be used to create scaffolds is biodegradable polymers 
(as reviewed by Eppley et al., 2005). 
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Many of the technologies described below can also be used to modify the surfaces of implants 
to stimulate the osseointegration process. 
 
Calcium phosphates 
Calcium phosphates include a wide variety of calcium phosphate based materials that have a 
composition that resembles real bone and can bind directly to it (as reviewed by Xie et al., 
2012). Many different chemical compositions exist (as reviewed by Eppley et al., 2005) the 
most common consisting of biphasic calcium phosphate, hydroxyapatite, β-tricalcium 
phosphate or some type of nonsintered calcium (as reviewed by Hallman and Thor, 2008). 
Calcium phosphate ceramics can be made into solid blocks, granulates, cements that are self-
setting and harden when inserted to the body and injectable preparations (as reviewed by 
Arisan et al., 2010 and Xie et al, 2012).  
 
A drawback with calcium phosphate ceramics is that their resorption (and hence their 
complete replacement with natural bone) often is reduced in vivo. An exception is β-
tricalcium phosphate that has a very rapid resorption rate, which actually limits its use (as 
reviewed by Hallman and Thor, 2008). 
 
Calcium phosphate cements are made from calcium orthophosphates and depending on how 
they are formed they can be divided into apatite and brushite cements (as reviewed by Xie et 
al., 2012).  Monetite, the material used in the in vivo experiment in this master thesis, can be 
made from dehydrated brushite cement (as reviewed by Tamimi et al., 2010). The two 
materials are similar but behave different in vivo because of differences in water solubility at 
physiological pH. Monetite does not form hydroxyapatite as brushite does, and this makes 
monetite more resorbable in vivo (as reviewed by Tamimi et al., 2010).  
 
Calcium sulfate  
The chemical structure of calcium sulfate is relatively simple and therefore the chemical 
composition cannot be varied as much as for calcium phosphates (as reviewed by Eppley et 
al., 2005). The material can be made into pellets, pastes, putty, chips and injectable forms  and 
in oral dentistry paste and putty are the most commonly used forms (as reviewed by Thomas 
and Puleo, 2009). Calcium sulfate is highly biocompatible and bioresorbable (as reviewed by 
Thomas and Puleo, 2009) and generally the material is substituted with bone within 8 weeks 
(definitely within 6 months) (as reviewed by Eppley et al., 2005). This rapid resorption can 
cause problems in implant dentistry since the material is degraded too fast to maintain enough 
space for the new bone formation (as reviewed by Hallman and Thor, 2008 and Thomas and 
Puleo, 2009) . 
 
Bioactive glass and glass ceramics 
Bioactive glass has an amorphous structure whereas glass ceramics are crystallized. The 
standard bioactive glasses are silica based (as reviewed by Rahaman et al., 2011). They also 
contain sodium, calcium and phosphate. When the glass is incorporated into the body and 
comes in to contact with body fluids reactions take place that form a hydroxyapatite layer on 
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the surface of the glass (as reviewed by Rahaman et al., 2011). This layer is osteoconductive. 
The main drawbacks with the glass are the slow degradation rate and difficulties when it 
comes to producing a stable porous piece (as reviewed by Rahaman et al., 2011). The slow 
degradation rate does not always match the new tissue formation and sometimes the material 
is not completely substituted with hydroxyapatite as it is meant to be (as reviewed by 
Rahaman et al., 2011).  
 
Biodegradable polymers 
Biodegradable polymers can either be natural-based (e.g. polysaccharides like starch and 
hyaluronic acid derivatives, or proteins like collagen, fibrin and silk) or synthetic (the most 
commonly used for scaffolding are saturated aliphatic polyesters e.g. lactic acid and glycolic 
acid) (as reviewed by Rezwan et al., 2006). Synthetic polymers have been used for sutures 
and internal fixation devices for several decenniums (as reviewed by Eppley et al., 2005).  
 
The synthetic polymers have strong mechanical properties and are highly biodegradable (the 
time varies with type of polymer) but have poor bioactivity (as reviewed by Rezwan et al., 
2006). 
 
Combinations of the materials  
In order to develop the ideal material with the perfect absorption time, biocompatibility and 
mechanical properties combinations of the different materials exists.  
 
Ceramics can be used together with biodegradable polymers to form composite materials that 
combine the osteoconductivity of the ceramic with the fast degradation time and strong 
mechanical properties of the polymer (as reviewed by Rezwan et al., 2006). Tamimi et al. 
(2012) mention that the enhancement of a ceramic with a polymer resembles the way the 
mineralized structure of bone is enhanced by proteins. 
 
Different ceramics can be combined. For example a combination of calcium sulfate and 
calcium phosphates in an in vivo study on dogs showed an increased formation of stronger 
bone than when calcium sulfate was used alone (Urban et al., 2007).  
 
Different compositions of the same type of material can also be combined. For example a 
porous calcium phosphate ceramic was combined with calcium phosphate cement in an in 
vivo study using sheep (Frayssinet et al., 2000). The cement was used to fill the pores in the 
ceramic and was progressively degraded so that new bone could grow into them. This 
enhanced the mechanical properties of the material but did not affect the amount of bone 
formed in the pores compared to a control, after 120 days. 
 
To reduce the amount needed, bone grafts can also be mixed with alloplastic substitutes (as 
reviewed by Hallman and Thor, 2008). 
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The rabbit as an animal model for implant research in bone 
In the development of new dental and orthopedic implants and associated biomaterials it is 
often necessary to use animal models before the products can be evaluated in human beings. 
In vitro methods with cell, tissue or organ cultures are initially used to test a new material but 
are not sufficient to determine if the material is biocompatible, mechanically functioning and 
safe in the human or animal body (as reviewed by Pearce et al., 2007 and Muschler et al., 
2010). Experimental animals must be used for testing biomedical devices if the data cannot be 
obtained elsewhere and is essential to characterize the tested material for the intended use and 
if no validated methods not using animals are available (ISO 10993-2:2006). For example, 
animals are needed to evaluate the local effects of an implant after implantation (ISO 10993-
6:2007). Relevant reduction and refinement strategies must also be identified and applied if 
animals are to be used (ISO 10993-2:2006). All implants sold in the European Union must be 
CE-marked. What the manufacturer must do to be allowed the mark on the product, is 
regulated in a directive (Council Directive 93/42/EEC). 
 
Recommended animal species to use are rodents, rabbits, goats, sheep, dogs and pigs (ISO 
10993-6:2007). They all have different advantages and disadvantages. Except for rodents the 
rabbit is the species with the least similarity to humans when it comes to histological bone 
structure and remodeling (as reviewed by Pearce et al., 2007). Rabbit long bones generally 
consist of primary bone tissue (as reviewed by Wang et al., 1998, Martiniaková et al., 2005) 
compared to the secondary of humans. Their bones also heal faster. Albrektsson et al. (1981) 
discuss that a dental implant placed in a rabbit long bone may only need 6 weeks to be 
osseointegrated whereas it takes 3-4 months in a human. This can make it difficult to 
extrapolate results from rabbit studies to humans (as reviewed by Pearce et al., 2007).  
 
Despite that, rabbits are often used in skeletal research (Neyt et al., 1998) since they have 
certain advantages in other aspects. 
 
Even though rabbits are small compared to goats, sheep and pigs, they are big enough for the 
placement of multiple implants. This is not possible in rats (as reviewed by Pearce et al., 
2007). Placement of multiple implants limits the number of animals needed in an experiment 
and makes it possible to use them as their own controls (as reviewed by Muschler et al., 
2010). However the size of a rabbit limits the amount of implants that can be placed (as 
reviewed by Pearce et al., 2007). The international standard for biological evaluation of 
medical devices (ISO 10993-6:2007) recommends a maximum of 6 implants/rabbit, the same 
recommendation for the larger animals are 12. The recommended size for screw-type implants 
placed in mid shaft (diaphysal) cortical rabbit bone is 2 – 4.5 mm (International Standard, ISO 
10993-6:2007). The standard does not state if this is the diameter or the length. For cylindrical 
implants the recommended size is 2 mm in diameter and 6 mm in length. 
 
Because of their size and temperament rabbits are easy to handle (as reviewed by Pearce et 
al., 2007) and it is possible to keep and observe many at the same time (as reviewed by 
Calasans-Maia et al., 2009). They are readily available and less expensive than larger animals 
(as reviewed by Mapara et al., 2012) and are more accepted as experimental animals to the 
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general public than dogs (as reviewed by Pearce et al., 2007). It is also convenient that rabbits 
develop and reach skeletal maturity fast. Skeletal growth in the New Zealand white rabbit is 
completed at 28 weeks of age (Masoud et al., 1986). 
 
In an experiment where the aim is to test bioactivity and feasibility of a material it is 
sufficient that the tissue into which the implant is put matches the tissue at the intended 
implantation site. This means it does not necessarily have to be placed in the intended 
anatomical location (as reviewed by Muschler et al., 2010). However, if the aim is to test if 
the material is functional in the clinical setting it is intended for, it is important to mimic the 
clinic as much as possible (as reviewed by Muschler et al., 2010). In dental research the 
implants are generally put in rabbit long bones, the tibia and femur are recommended (ISO 
10993-6:2007, Mapara et al., 2012). The rabbit jaw is too small for human standard size 
implants (as reviewed by Mapara et al., 2012). There are however studies where the first 
upper molars have been extracted and implants have been placed in rat maxillae, but these 
implants were smaller than standard, only 1,14 mm in diameter and 2,01 mm in length 
(Shirakura et al., 2003).  Different locations can be chosen depending on what human 
anatomical site it should resemble. Sennerby et al. (1992) used the tibial methaphyses as sites 
resembling the more compact bone in the mandibula and the epiphysis of the femur in the 
knee-joint as a site resembling the more cancellous bone in the maxilla. The cortical thickness 
of the rabbit tibial diaphysis and metaphyses is about 1.2-1.5 mm (Lind et al., 1993, Ivanoff et 
al., 1997, as reviewed by Cho et al., 2010) and the length of the bone in a full-grown rabbit is 
about 11cm (Masoud et al., 1986). 
 
A disadvantage with placing the implant in long bones instead of the jaws is that  loading it 
with a dental prosthesis is not possible (as reviewed by Mapara et al., 2012). However they 
can be tested under different loads with the use of special devices (Roberts et al., 1984, Uysal 
et al., 2012). 
 
In conclusion the rabbit is a good model to start with before testing implants and associated 
materials in a larger animal model (as reviewed by Pearce et al., 2007). 
 
MATERIALS AND METHODS 
Animals 
Three female New Zeeland White rabbits, 12 months old, were used in this study. The rabbits 
were bought from a licensed breeder (Lidköpings kaninfarm, Sweden). The rabbit colony was 
health monitored according to recommendations by FELASA (Nicklas et al., 2002) and found 
to be free from the following pathogens: rabbit hemorrhagic disease virus, rabbit rota virus/ 
rabbit corona virus, Bordetella bronchiseptica, Clostridium piliforme, dermatophytes, 
Pasteurella multocida, other Pasteurellaceae, Salmonella spp., ectoparasites and pathogenic 
endoparasites. 
 
The rabbits were numbered 2057, 2271 and 2277 and and on arrival their body weights were 
4.13 kg, 4.83 kg and 4.67 kg respectively. During acclimatization the rabbits were kept 
together in a floor pen of 3m2, enabling them social contact and free movement. Aspen 
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shavings were used for bedding and the pen was cleaned weakly. Plastic boxes served as 
hiding places and look-outs.. The room temperature was 20 ± 2°C and humidity 55 ± 10% and 
the light-dark-cycle was 12:12 hours with lights on at 0600 hours.  
 
The rabbits were fed autoclaved hay (ad libitum) and a standard pelleted rabbit diet (Lactamin 
K3, Lantmännen, Sweden). Access to water was ad libitum. 
 
The experiment was approved by the local ethical committee for animal experiments (Dnr 
C131/11). 
 
Materials 
Each rabbit received 2 screw type titanium implants (Straumann® Bone Level, SLActive 
implant, Institut Straumann AG, Basel, Switzerland) per tibia. The screws were 8 mm long 
and 3.3 mm in diameter. Around 2 of the implants in each rabbit the experimental “Ångström 
ceramic” was applied whereas the other 2 implants were surrounded by either a bone ceramic 
(Straumann® BoneCeramic, Institut Straumann AG, Basel, Switzerland) as a positive control 
or blood as negative control, see table 1.  
 
Preparations 
The rabbits were acclimatized and accustomed to handling during 2.5 weeks prior to the 
study. Their body weight was monitored daily, for comparison with body weight post-
surgery, as an aid to evaluate recovery. The rabbits were trained to eat from a syringe in case 
supplemented feeding would be necessary post-surgery. Three days before surgery the fur on 
the ears of the rabbits was clipped, to enable vessel catheterization at the time of surgery.  
 
Pre-medication and anesthesia 
On the day of surgery the rabbits were sedated in the pen with 0.1 mg/kg medetomidine 
(Domitor® 1 mg/ml, Orion Pharma AB, Animal Health, Sollentuna, Sweden) subcutaneously 
(SC), 20 minutes before being transported to the operating theater. On both ears a local 
anesthetic cream containing lidocaine and prilocaine (Emla®, 25 mg/g + 25 mg/g, 
AstraZeneca AB, Södertälje, Sweden) was applied. 
 
In the preparation room 5 mg/kg enrofloxacin (Baytril® 25 mg/ml, Bayer A/S, Animal Health 
Division, Copenhagen, Denmark) and 2 mg/kg carprofen (Rimadyl® vet. 50 mg/ml. Orion 
Pharma AB, Animal Health, Sollentuna, Sweden), were administered SC. An arterial catheter 
was placed in one ear for monitoring of blood gases and blood pressure and a venous catheter 
in the other ear for infusion of anesthetic drugs and fluids. The fur on the tail was clipped and 
an O2-saturation probe applied.  
 
Anesthesia was induced and maintained by an intravenous infusion consisting of 2.3 μg/ml 
sufentanil (Sufenta®, 50 μg/ml, Janssen-Cilag AB, Sollentuna, Sweden) and 0.45 mg/ml 
midazolam (Midazolam Actavis, 1 mg/ml, Actavis AB, Stockholm, Sweden). After induction 
the larynx was sprayed with lidocaine (Xylocain®, 20 mg/ml, AstraZeneca AB, Södertälje, 
Sweden) and the trachea was intubated with a 3 or 3.5 Fr endotracheal tube using a special 
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laryngoscope (Flecknell™, Alstoe Ltd. Animal Health, York, UK).  During induction oxygen 
was administered by face mask. When intubation was completed the endotracheal tube was 
attached to the anesthesia machine and a fresh gas flow of 1 l oxygen + 2 l air was 
administered. A ventilator was used as needed to maintain a physiological level of arterial 
CO2 pressure.  
 
Respiratory rate, heart rate, blood pressure, O2-saturation, body temperature and EtCO2 were 
monitored throughout anesthesia. Before induction of anesthesia, 2.5 ml of arterial blood was 
sampled for analysis of Serum Amyloid A and a white blood cell differential count. 
Additional arterial blood (0.1 ml) was drawn from the arterial catheter before induction and 
subsequently every 30 minutes throughout anaesthesia for blood gas analysis with a portable 
blood gas machine (i-STAT® system, Abbot Point of Care inc., Princeton, New Jersey). 
Intra-venous fluid was administered during anesthesia using either 10 ml/kg/h Ringer-Acetate 
or 15 ml/kg/h Voluven® (Fresenius Kabi AB, Uppsala, Sweden). The rabbit was kept on a 
heat pad during surgery. 
 
Surgery 
The surgical sites, medial part of tibia, were prepared by clipping the fur on both hind limbs 
from the ankles to above the knees. The skin was washed with soap and water followed by 
disinfection with Clorhexidine-Alcohol. The rabbit was then transported from the preparation 
room to the operating theatre where it was placed on its back, a final antiseptic wash was 
performed and the rabbit draped was for sterile surgery. 
 
Each incision line was subcutaneously infiltrated with a maximum of 1 mg/kg bupivacaine 
(Marcain® 2.5 mg/ml, AstraZeneca AB, Södertälje, Sweden). The skin was incised and the 
subcutaneous tissue dissected all the way down to the bone. Two implant beds, one in the 
proximal diaphysis and one in the central diaphysis, at a distance of 2.5 cm in between, were 
prepared in each tibia. By intermittent drilling with a 3.2 mm drill bit during irrigation with 
saline, 6 mm deep cavities reaching into the medulla were created.  
 
The bone implants were screwed into each cavity, leaving 2 mm of the implant above the 
bone surface. Thereafter one of the bone augmenting materials was applied around the 
protruding implant, or blood was allowed to fill the space (see table 1). The “Ångström 
ceramic” was distributed subperiostally around the implants in two rabbits, on the left tibia 
(experimental side). In one rabbit the “Ångström ceramic” was injected into the cavitites on 
the left tibia before installation of the implants. On the right tibia (control side) Straumann® 
BoneCeramic was applied around the implants on one rabbit, and on two rabbits the space 
was left to fill with blood.  
 
Table 1. Distribution of materials and titanium implants in the three rabbits 
Rabbit # Left tibia implants (n = 2) Right tibia implants (n = 2) 
2057 ”Ångström ceramic” subperiostally  Straumann® BoneCeramic  
2271 ”Ångström ceramic” subperiostally  Blood  
2277 ”Ångström ceramic” intra-medullary  Blood  
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The implant stability was measured with resonance frequency analysis (using apparatus from 
Osstell AB, Gothenburg, Sweden) before the periosteum and skin was sutured with resorbable 
sutures (Vicryl® 4-0, Ethicon inc., Somerville, New Jersey). 
 
After closure of the skin 0.03 mg/kg buprenorphine (Temgesic® 0.3 mg/ml, RB 
Pharmaceuticals Limited, Slough, UK) was given intravenously (IV) and 0.02 mg/kg SC. 
After extubation of the airways, the rabbit was put in a cage under a heat lamp during 
recovery. The time to return of the righting reflex was noted and if it did not return within 15 
minutes, 0.05 mg/kg flumazenil (Lanexat® 0.1 mg/ml, Roche AB, Stockholm, Sweden) was 
administered IV. The rabbit was monitored until sitting up, fully awake, after which it was 
returned to the animal department. 
 
Post-operative care 
Postoperatively the rabbits were kept individually in pens of 2-3 m2. The pens allowed for the 
animals to see, hear and smell each other.  
 
The appetite was closely monitored and if the rabbit did not eat within 12 hours post surgery 
it was fed with a syringe twice a day with Critical Care (Oxbow Animal Health, Murdock, 
Nebraska), in a dosage according to weight. If the rabbit did not drink properly, water was 
given by the mouth or Ringer-Acetate was administered SC.  
 
Post-operative pain control was achieved with subcutaneous administration of 0.05 mg/kg 
buprenorphine every 12 hours and carprofen 2 mg/kg every 24 hours for 3-5 days. The rabbits 
were closely monitored for signs of pain (not eating, abnormal body posture, reluctance to 
move or aggression) and additional pain medication was given if necessary. Enrofloxacin  
(5 mg/kg) was administered subcutaneously every 12 hours for 3 days post-surgery for 
infection prophylaxis.  
 
For one week post-surgery the rabbit’s body weight was recorded daily. The rabbit’s general 
condition, condition of the surgical wound and degree of limping was evaluated every day for 
as long as needed. The limping was graded using a 0-5 scale, with 0 being no limping and 5 
being no usage of the leg. 
 
According to the ethics permit, the humane end-points (reason for euthanasia) were; loss of 
15% or more of the body weight compared to the day of surgery; signs of infection; poor 
general condition or severe diarrhea. If the rabbit only showed mild-moderate signs of illness, 
veterinary treatment could be attempted. 
 
The plan was to keep the rabbits for 3 months after surgery, and record the body weight once 
a week, after the first week. Two weeks post surgery calcein green, a fluorescent bone marker 
that is deposited along the mineralization front of newly formed bone at the time of injection 
(as reviewed by Turner et al., 1995), was supposed to be administered through an intravenous 
ear catheter. After euthanasia, the implant stability was to be measured with resonance 
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frequency analysis, before taking out blocks of the bone containing the implants and 
surrounding tissues for histological preparation. The amount of newly formed bone was to be 
evaluated with a light microscope and the osseointegration measured histomorphometrically 
as bone to implant contact in percent. 
 
Euthanasia 
The rabbits were pre-medicated in the pen with 0.1 mg/kg medetomidine given 
subcutaneously. Local anesthetic cream (EMLA) was applied on the ear and 2 ml/kg of the 
euthanasia solution (Pentobarbital 100 mg/ml, Allfatal vet., Omnidea AB, Stockholm, 
Sweden) was administered into the ear vein. 
  
RESULTS  
Anesthesia, surgery and recovery  
Anesthesia and surgery were uneventful. The airways of all rabbits needed to be mechanically 
ventilated. The body temperature was maintained over 36.8 °C during anesthesia.  
 
All implants were satisfactorily placed and were stable when tested with resonance frequency 
analysis. The duration time of surgery varied between 90 and 120 minutes.  
 
Rabbits # 2271 and 2277 regained the righting reflex within 10 minutes after ending 
anaesthesia. Rabbit # 2057 was given flumazenil post-surgery and the righting reflex then 
returned within 5 minutes. All rabbits started eating during the first 12 hours post-surgery. 
 
First week post-surgery 
The first two days post-surgery the rabbits recovered well. Rabbit # 2057 was limping 
slightly, with a score of 2 on the left hind limb. The operation wounds looked fine and the 
general condition was good. Rabbit # 2271 was not limping and did not show signs of illness 
the first day post-surgery, but on the second day it dragged its left leg behind. Closer 
examination revealed that both tibias were fractured and the rabbit was euthanized. Rabbit # 
2277 moved well and was in good general condition. The left hind limb was slightly swollen 
laterally on the tibia.  
 
Three days post-surgery the right tibia of rabbit # 2057 was fractured while the rabbit was 
struggling when being handled. The rabbit was euthanized. Rabbit # 2277 showed no signs of 
illness, was not limping and the operation wounds looked fine. Four days post-surgery Rabbit 
# 2277 stopped eating and was syringe fed. Five days post-surgery the rabbit did not show 
any signs of pain or infection and treatment with buprenorphine and enrofloxacin was 
discontinued. Treatment with carprofen was continued for two more days.  
 
Second and third week post-surgery 
During the second week post-surgery rabbit # 2277 was active and moved normally but 
continued to eat poorly and was supplementary fed with Critical Care. Ten days post-surgery 
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it showed a slight limping on the left hind limb (score 1). From post-surgery day 11-14 the 
rabbit was very energetic and struggled while being fed. On day 15 the rabbit had lost 14 % of 
its body weight. By day 21 post-surgery the limping had disappeared, the rabbit was active 
and had company by another rabbit in the opposite pen. A shallow wound, 3 mm long, could 
be seen on one tibia and there were traces of blood in the fur. Calcein green was not 
administered.  
 
On day 24 post-surgery the rabbit was not using the left hind limb. The tibia was found to be 
fractured and the rabbit was euthanized. During the last four days the rabbit lost 35 g (8 %) in 
body weight. Representing a total loss of 13 % compared to the day of surgery. The pre and 
post-surgery weights for all three rabbits are displayed in figure 4. 
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Figure 4. Body weight of three NZW rabbits before and after surgery with implantation of two bone 
screws per tibia. Day  0 represents the day of surgery. 
 
Post-mortem examination 
The right tibia of rabbit # 2057, for which Straumann® BoneCeramic was used, was fractured 
obliquely at the level of the distal implant (figure 5). The left tibia was not fractured but the 
examination showed that the “Ångström ceramic” was not in place but had spread in the 
surrounding tissues, (figure 6).  
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Figure 5. Right tibia of rabbit # 2057, fractured at the level of the distal implant (white arrow). 
Straumann® bone ceramic was used. With permission of the principle investigator. 
 
 
Figure 6. Left tibia of rabbit # 2057. The “Ångström cermic” has spread out in the tissues 
surrounding the implants (white arrows). With permission of the principle investigator. 
 
The left tibia of rabbit # 2271 was fractured just distally of the distal implant (figure 7) and 
the “Ångström ceramic” had spread out. The right tibia, in which no bone augmenting 
material had been used, was fractured at the level of the distal implant (figure 8). Both 
fractures were slightly oblique. 
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Figure 7. Left tibia of rabbit # 2271, fractured just distally of the distal implant. The “Ångström 
ceramic” has spread out in the tissues surrounding the implants (white arrows). Black arrows mark 
the implants. With permission of the principle investigator. 
 
 
Figure 8. The right tibia of rabbit # 2271, fractured at the level of the distal implant. No bone 
augmenting material was used. With permission of the principle investigator. 
 
Palpation of the left tibia in rabbit # 2277 showed that it was fractured at the level of the distal 
implant.  
 
Table 2 shows the material that was used and the location of the fractures.  
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Table 2. Display of materials used and legs fractured in each rabbit 
Rabbit # Left tibia implants (n = 2) Right tibia implants (n = 2) 
Fractured 
leg 
2057 ”Ångström ceramic” subperiostally Straumann® BoneCeramic  right 
2271 ”Ångström ceramic” subperiostally Blood  both 
2277 ”Ångström ceramic” intra-medullary Blood  left 
 
DISCUSSION   
The aim of the pilot study was to evaluate the feasibility and the result of the experimental 
protocol. The protocol was designed for evaluation of a new bone augmenting material. Two 
titanium implants were placed in each tibial diaphysis in three rabbits. The implants were 
surrounded by the experimental monetite-based calcium phosphate ceramic (the “Ångström 
ceramic”) or the controls; Straumann® BoneCeramic or blood. The results were supposed to 
be evaluated three months after implantation, but the pilot study had to be terminated within 
24 days since all three rabbits fractured one or two tibias.  
 
Post-surgical monitoring 
The rabbits’ body weights were recorded pre- and post surgery and a limping score (0-5), was 
used post-surgery, to evaluate recovery.  
 
Anorexia has been shown to be good a good indicator of pain in New Zealand White rabbits 
(Weaver et al., 2010). An indirect way of monitoring food intake is by recording body weight. 
By monitoring body weight pre- and post-surgery it is therefore possible to evaluate recovery. 
In experimental research, so called “humane end points” are used to minimize suffering of 
animals. The end points are suggested by the principal investigator and determined by the 
local animal ethical committee. One of the humane end-points for this experiment was a 
weight-loss of more than 15% compared with the body weight on the day of surgery (pre-
surgery weight). The rabbits recovered well during the first days after surgery. Rabbits # 2271 
and # 2057 only lived for two and three days post-surgery and their body weight and general 
condition were not close to any of the humane end-points until the tibias fractured, and the 
rabbits were euthanized. Rabbit # 2277 lived the longest and had lost 14 % of its body weight 
by day 15 post-surgery. After that the rabbit gained weight again so that it reached 95% of the 
pre-surgery weight. However, before it fractured its tibia, the rabbit lost 8 % of its current 
body weight in four days. This rapid weight-loss indicates that the rabbit was in pain. Four 
days before the tibia fractured, there was no obvious limping, but a small wound and blood in 
the fur was noted on one of the legs. This may have been a sign of pain, since rabbits can 
groom themselves excessively, up to the point of self-mutilation, in areas that have been 
exposed to trauma (Hess and Tater, 2012). 
 
Rabbit #2277 stopped eating for a period after the other two rabbits had been euthanized and 
it was the only one left. Rabbits are known to show signs of depression, e.g. lethargy and 
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decreased appetite, when loosing group members (Bradley Bays, 2012). Since rabbits are 
known to be social animals, a new rabbit was acquired to keep # 2277 company. After this the 
rabbit became more active and the appetite increased again.    
 
Tibial fractures 
A bone fractures when it is subject to forces exceeding its tensile strength. This can occur 
because of trauma or fatigue (as reviewed by Wang et al., 1998). The bone can also be 
weakened by pathological processes and therefore fracture when subjected to forces it 
normally tolerates.  
 
Depending on what type of force is applied the bone fractures in different ways. Compressive 
forces that apply pressure on the bone along the longitudinal axis (see fig. 9), generally lead to 
oblique fractures (Johnson 2007a). Depending on the level of energy involved a bone 
fractures into many pieces (high energy) or it fractures into two pieces (low energy). In this 
study the bones fractured obliquely into two pieces suggesting a low energy compressive 
force.  
 
 
Fig 9. Schematic illustration of compressive forces on a long bone leading to an oblique fracture. 
Made by Lovisa Nalin based on the information by Johnson, 2007a.  
 
Implant size and number 
When an implant is placed in bone, the area is always damaged to some extent i.e. subject to 
trauma (as reviewed by Davies, 2003). The bone in that area is thus weakened, as in a 
pathological process, and might not withstand normal loading.  
 
The recommended size for screw-type implants in the international standard (ISO 10993-6: 
2007) probably concerns the diameter of the implant. It corresponds well with implant 
diameters used in these types of experiments (see table 3). Screw type implants can be 
inserted through a shorter extent of bone than the length of the implant. For example, in the 
present pilot study an 8 mm screw was inserted 6 mm into the bone. Maybe that is why no 
length recommendation is given in the international standard (ISO 10993-6: 2007).  
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The screw diameter in the present pilot study was 3.3 mm, which is within the recommended 
interval of 2-4.5 mm. In table 3 the size and number of tibial implants in 20 experiments 
using New Zealand White rabbits are displayed. The diameter of the implants in all 
experiments but one (Ivanoff et al., 1997) was within the recommended ISO range, but the 
lengths vary quite a lot. Moreover the aim of the experiment by Ivanoff et al. (1997) was to 
evaluate implant designs that were wider than normal. All implants in the studies in table 3 
were not inserted into their full extent and in some of the experiments additional implants 
were placed in the femur, but none exceeded the 6 implants/rabbit recommended. None of the 
studies included in table 3 report any post-surgical fractures in the rabbits. 
 
Mapara et al. (2012) recommend  that only one implant should be placed in each leg and that 
if two are placed, they should be as small as possible because the of the fracture risk. Two 
implants/leg were placed in the present study but given the recommendations in the 
international standards and the use of more than one implant in 15 of the 20 experiments in 
table 3 this is probably not the main reason why the tibias fractured.  
 
Table 3. Display of implant size and number in 20 recent experiments using screw type implants 
placed in the tibia of New Zealand White rabbits. None reported post-surgery fractures. Search terms: 
rabbit AND tibia AND (screw OR thread) AND implant 
Article Implants/tibia 
(n) 
Implant length  
(mm) 
Implant diameter 
 (mm) 
Grandfield et al., 2012 2 5 3.75 
Liu et al., 2012 1 18 2.5 
Uysal et al., 2012 2 8 1.4 
Hsu et al., 2011 1 8 3.6 
Park, 2011 1 5.3 3.3 
Poulos et al., 2011 2 7 3.75 
Reigstad et al., 2011 2 8 3.75 
Shin et al., 2011 2 6.6 3.3 
Cho et al., 2010 2 8.3 3.8 
Palmquist et al., 2010 2 5 3.75 
Lee et al., 2009 2 7 3.75 
Sul et al., 2009 3 7. 8 3.75/4 
Cordioli et al., 2000 2 4 3.75 
Rasmusson et al., 1998 1 8 3.75 
Ivanoff et al., 1997 2 6 3.0/ 3.75/ 5.0/ 6.0 
Meredith et al., 1997 2 10 3.75 
Larsson et al., 1996 2 4 3.75 
Piattelli et al., 1996 1 Not mentioned 4.0 
Sennerby et al., 1993 2 4 3.75 
Sennerby et al., 1992 2 4 3.75 
 
Implant location 
In the present study, the implants were put into the proximal and middle part of the tibial 
diaphysis. This area seems to be sensitive for both traumatic and stress-induced fractures in 
rabbits. According to the experience of Zehnder and Kapatkin (2012) the most common sites 
for fractures in rabbits are the femur and the tibia/fibula. The combination of a fragile 
skeleton and powerful musculature makes the hind limb and back sensitive for fractures in 
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rabbits and they can easily injure themselves while struggling when being restrained 
(Graham, 2012). 
 
Stress fractures arise when repetitive loading results in faster break-down than regeneration of 
the bone (Johnson 2007a) and in humans the most common site for stress fractures is the tibia 
(as reviewed by Burr et al., 1990). Two experimental studies have indicated that the middle 
part of the tibial diaphysis in rabbits is also sensitive for this type of lesion. Li et al. (1985) 
provoked rabbits to jump and run excessively by giving them electrical shocks in a controlled 
manner. Most signs of bone injury were seen in the middle third of the tiba. Burr et al. (1990) 
developed a rabbit animal model for studying the etiology of tibial stress fractures. In their 
model one hind limb of the animal was repetitively loaded in a special device and stress 
fractures developed in the middle and distal parts of the tibial diaphysis. The most common 
site was the midshaft of the bone where 89% of the fractures occurred.  
 
Table 4 displays the anatomic locations of the implants in the same studies as in table 3. It is 
difficult to know the exact locations of the implants since most articles do not mention if it 
was laterally, medially, cranially or caudally in the bone. There also seems to be some 
confusion about the fact that a bone has two metaphyses, since some articles just state stat the 
implant was placed in the metaphysis. But clear is that the tibial metaphysis is the most 
common site. The diaphysis was only used in one of the experiments in table 4 (Shin et al., 
2011) in which two implants were said to have been placed in that location. However, based 
on the description in the article, the proximal implant was placed 11mm distal of the patella, 
which is likely to be in the metaphysis.  
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 Table 4. Display of implant locations and number in the 20 experiments in table 3 
Article Implant location Implants/tibia (n) 
Grandfield et al., 2012 Proximal and distal tibial metaphysis 2 
Liu et al., 2012 Proximal tibial metaphysis 1 
Uysal et al., 2012 Proximal anterior tibia 2 
Hsu et al., 2011 Proximal tibial metaphysis 1 
Park, 2011 Medial proximal tibia 1 
Poulos et al., 2011 Tibial metaphysis (not mentioned which) 2 
Reigstad et al., 2011 Medial proximal tibia near tibial tuberosity 2 
Shin et al., 2011 Medial tibial diaphysis 2 
Cho et al., 2010 Left and right side of proximal tibia 2 
Palmquist et al., 2010 Proximal and distal tibial metaphysis 2 
Lee et al., 2009 Lateral flat surface of proximal tibia 2 
Sul et al., 2009 Implants placed on a longitudinal row from proximal 
to distal on the tibia but not described where or how 
far apart  
3 
Cordioli et al., 2000 Tibial metaphysis (not mentioned which) 2 
Rasmusson et al., 1998 Proximal tibial metaphysis 1 
Ivanoff et al., 1997 Cranial cortex, proximal and distal on the metaphysis 
(not mentioned which but looks like the proximal one 
in a figure) 
2 
Meredith et al., 1997 Proximal metaphysis of right tibia 2 
Larsson et al., 1996 Proximal tibial bone 2 
Piattelli et al., 1996 Tibial metaphysis (not mentioned which) 1 
Sennerby et al., 1993 Tibial metaphysis (not mentioned which) 2 
Sennerby et al., 1992 Tibial metaphysis (not mentioned which) 2 
 
Housing considerations 
The rabbits in this study had access to 2-3 m2 of cage floor area each directly after surgery 
and despite the acclimatization period and handling during 2.5 weeks before the operations 
they were easily scared and “jumpy”. One rabbit fractured the leg when struggling while 
being handled and another one struggled vigorously whilst being syringe fed.  
 
While researching for the background only two articles concerning post-operative care 
measures for rabbits used in experimental surgery were found (Calasans-Maia et al., 2009, 
Mapara et al., 2012). Both articles recommend that the rabbits are returned to their home 
cages after surgery and are closely monitored for signs of pain. Mapara et al. (2012) write that 
it is important to supervise the rabbit until it is fully awake since it can start moving 
excessively and uncontrollably and fracture its legs when it recovers from anesthesia.  
The recommended home cages in both articles were smaller: (0.90m x 0.60m, giving a floor 
area of 0.54 m2) than the pens used in our experiment and the rabbits were kept individually 
pre- and post-surgery. Mapara et al. (2012) mention that movement should be restricted by 
placing boxes in the cage if the rabbit has already fractured its leg. The international standard 
describing suitable species and implant sizes for testing biomedical devices (ISO 10993-
6:2007) do not mention how rabbits should be kept after surgery. The international standard 
describing animal welfare requirements in experiments testing biomedical devices (ISO 
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10993-2:2006) states that relevant post-surgical measures must be undertaken and analgesics 
administered responsibly and effectively. 
 
In the current experiment the distal implant was placed in the midshaft of the tibia which was 
where they later on fractured. Giving that this area seems to be prone to fracturing by 
excessive running and jumping in the normal rabbit, the combination of the trauma from 
surgery, the space provided in the pens and the nervousness of the rabbits may explain why 
the tibias fractured. To prevent this from occurring, the post-operative care should probably 
be similar to that of a surgically fixated fracture. In dogs and cats that have undergone fracture 
fixation surgery the only movement allowed is controlled rehabilitation training and leash 
walks until the fracture has healed, which is continuously followed up with x-ray 
examinations (Johnson, 2007b). According to Richardson (2000) rabbits that have had 
external or internal fracture fixation should be confined in a stress-free environment and 
healing is normally completed within 6 weeks. 
 
In the experimental setting it may be recommendable to restrain the movements of the rabbits 
by keeping them in individual cages initially after surgery. According to the European 
directive regarding the protection of research animals (Directive 2010/63/EU of the European 
parliament and of the council) the minimum floor area for one rabbit is 0.42 m2 and the 
minimum cage height 45 cm. The enclosure must have a raised area covering no more than 40 
% of the floor and the rabbit must be able to sit and lie under it. If a raised area cannot be used 
for medical reasons, the area of the enclosure must be increased with 33 %, which 
corresponds to a floor area of 0.56 m2. This area is much smaller than the areas of the pens 
used in the current experiment.  
 
None of the 20 articles in table 5, mention restriction of movement as a post-operative 
measure and the cage size is not stated in any of the 20 articles. Only in three of the articles is 
it mentioned that the rabbits were kept in cages or pens, in the others there is no information 
about housing. Of the 20 articles, 14 do not mention if animals were kept singly, in pairs or in 
groups. In 9 of the experiments male rabbits were used and they were most likely kept 
separately because of the risk of fighting. In two articles group housing is reported 
(Rasmusson et al, 1998. Palmqvist et al., 2010) and in one of them it was stated that the 
rabbits were kept individually post surgery (Palmquist et al., 2010). Post-operative measures 
related to housing or movement was only mentioned in 6 of the 20 articles and the most 
common information was that the animals were kept separately and allowed immediate full 
weight-bearing on the legs.  
 
To keep the rabbits from struggling and injuring themselves while being handled they should 
be carefully restrained, e.g. by placing them in a box or in the lap. They can also be wrapped 
in a towel or one person can firmly hold the rabbit and another person administer medications, 
food etc.  
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Table 5. Housing and post-operative movement of the rabbits in the articles from table 3 
Article Cage/Pen size (m2) rabbits/cage Rabbit sex Post-operative  
housing and 
movement 
Country 
Grandfield et al., 2012 Not mentioned how 
kept 
Not 
mentioned 
Not mentioned Not described Sweden 
Liu et al., 2012 According to 
university 
guidelines 
Not 
mentioned 
Male Not described China 
Uysal et al., 2012 Standard cage 1 Male Not described Turkey 
Hsu et al., 2011 According to 
university 
guidelines 
Not 
mentioned 
Male Not described China 
Park, 2011 Not mentioned how 
kept 
Not 
mentioned 
Male Not described Korea 
Poulos et al., 2011 Not mentioned how 
kept 
1 Male Not described USA 
Reigstad et al., 2011 Not mentioned how 
kept 
1 Female Not described Norway 
Shin et al., 2011 Not mentioned how 
kept 
Not 
mentioned 
Male Not described USA 
Cho et al., 2010 Not mentioned how 
kept 
Not 
mentioned 
Male Kept seperatly, 
allowed  
full weight-bearing 
immediatly 
Korea 
Palmquist et al., 2010 Not mentioned how 
kept 
Group 
housing 
Female Kept seperatly for 7 
days post-surgery 
Sweden 
Lee et al., 2009 Not mentioned how 
kept 
1 Both Kept seperatly, 
allowed full weight-
bearing immediatly 
Korea 
Sul et al., 2009 Not mentioned how 
kept 
Not 
mentioned 
Male Kept seperatly, 
allowed full weight-
bearing immediatly 
Sweden 
Cordioli et al., 2000 Not mentioned how 
kept 
Not 
mentioned 
Not mentioned Full weigh-bearing 
and movement 
immediatly 
Italy 
Rasmusson et al., 1998 Kept in purpose-
designed room 
10 Female Not described - 
Ivanoff et al., 1997 Standard cage Not 
mentioned 
Both Not described Sweden 
Meredith et al., 1997 Not mentioned how 
kept 
Not 
mentioned 
Female Not described - 
Larsson et al., 1996 Not mentioned how 
kept 
Not 
mentioned 
Both Not described Sweden 
Piattelli et al., 1996 Not mentioned how 
kept 
Not 
mentioned 
Male Not described Italy 
Sennerby et al., 1993 Not mentioned how 
kept 
Not 
mentioned 
Both Not described - 
Sennerby et al., 1992 Not mentioned how 
kept 
Not 
mentioned 
Both The animals were 
allowed post-operative 
movement 
- 
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The “Ångström” ceramic 
Given that 2 right and 2 left tibiae fractured and the “Ångström” ceramic was only used on 
the left side, there are no indications that the new material caused the fractures. However the 
material needs to be modified for future experiments since it did not stay in place around the 
implant as intended but had spread in the surrounding tissues. This suggests that it did not set 
and harden as intended. The setting properties of the material should thus be altered. 
 
Summary 
The implants were placed in an area of the bone that is sensitive to fracturing in healthy 
rabbits. When the area was weakened by surgery and placement of the implants the 
compressive forces affecting the bone when the rabbits moved around became too much and 
the bone fractured. 
 
CONCLUSION 
The rabbit is a commonly used animal in this type of research and it is a good model to start 
with when testing bioactivity and feasibility (as reviewed by Pearce et al., 2007 and Muschler 
at al., 2010). 
 
This experiment shows how important it is to start with a pilot study using few animals to 
evaluate an experimental design. This protocol failed, but only three rabbits had to be 
sacrificed which is more ethical and economical than a failed full scale experiment. The pilot 
makes it possible to modify the protocol for future experiments. The modifications should 
include selecting a different anatomic site for placing the implants, restricting the movement 
of the rabbits post-operatively and modifying the setting properties of the “Ångström” 
ceramic. 
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